Healthcare settings can amplify transmission of Middle East respiratory syndrome coronavirus (MERS-CoV), but knowledge gaps about the epidemiology of transmission remain. We conducted a retrospective cohort study among healthcare personnel in hospital units that treated MERS-CoV patients. Participants were interviewed about exposures to MERS-CoV patients, use of personal protective equipment, and signs and symptoms of illness after exposure. Infection status was determined by the presence of antibodies against MERS-CoV. To assess risk factors, we compared infected and uninfected participants. Healthcare personnel caring for MERS-CoV patients were at high risk for infection, but infection most often resulted in a relatively mild illness that might be unrecognized. In the healthcare personnel cohort reported here, infections occurred exclusively among those who had close contact with MERS-CoV patients.
Healthcare settings can amplify transmission of Middle East respiratory syndrome coronavirus (MERS-CoV), but knowledge gaps about the epidemiology of transmission remain. We conducted a retrospective cohort study among healthcare personnel in hospital units that treated MERS-CoV patients. Participants were interviewed about exposures to MERS-CoV patients, use of personal protective equipment, and signs and symptoms of illness after exposure. Infection status was determined by the presence of antibodies against MERS-CoV. To assess risk factors, we compared infected and uninfected participants. Healthcare personnel caring for MERS-CoV patients were at high risk for infection, but infection most often resulted in a relatively mild illness that might be unrecognized. In the healthcare personnel cohort reported here, infections occurred exclusively among those who had close contact with MERS-CoV patients.
Between 12 and 16 October 2014, the National IHR Focal Point for the Kingdom of Saudi Arabia (KSA) notified WHO of 5 additional cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection, including 2 deaths.
In 2012, the first cases of infection with the Middle East respiratory syndrome coronavirus (MERS-CoV) were identified. Since then, more than 1,000 cases of MERS-CoV infection have been confirmed; infection is typically associated with considerable morbidity and, in approximately 30% of cases, mortality. Currently, there is no protective vaccine available. Replication-competent recombinant measles virus (MV) expressing foreign antigens constitutes a promising tool to induce protective immunity against corresponding pathogens. Therefore, we generated MVs expressing the spike glycoprotein of MERS-CoV in its full-length (MERS-S) or a truncated, soluble variant of MERS-S (MERS-solS). The genes encoding MERS-S and MERS-solS were cloned into the vaccine strain MVvac2 genome, and the respective viruses were rescued (MVvac2-CoV-S and MVvac2-CoV-solS). These recombinant MVs were amplified and characterized at passages 3 and 10. The replication of MVvac2-CoV-S in Vero cells turned out to be comparable to ...
Between 13 and 14 March 2016, the National IHR Focal Point for the Kingdom of Saudi Arabia notified WHO of 4 additional cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection. One of these reported cases is linked to the MERS-CoV outbreak currently occurring in a hospital in Buraidah city.
Since its first emergence in 2012, cases of infection with Middle East respiratory syndrome coronavirus (MERS-CoV) have continued to occur. In this study, we present two nucleic acid visualization assays that target the MERS-CoV UpE and N genes as a p
Middle East respiratory syndrome coronavirus From Wikipedia, the free encyclopedia (Redirected from Middle east respiratory syndrome coronavirus) This article is about the virus. For the disease, see Middle East respiratory syndrome. For the outbreak, see 2012 Middle East respiratory syndrome coronavirus outbreak. For general about the virus, see Coronavirus. MERS-CoV MERS-CoV particles…
Coronaviruses are common viruses that can affect humans and animals. Coronaviruses are medium-sized enveloped positive-stranded RNA viruses whose name comes from their characteristic crown-like appearance in electron micrographs. Coronaviruses are widespread among birds and mammals, with bats being the largest host of various genotypes1. Human coronaviruses were first identified in the mid-1960s2. There are two genera of human coronaviruses: alpha coronaviruses and beta coronaviruses. The Middle East respiratory syndrome coronavirus/MERS-CoV, and severe acute respiratory syndrome coronavirus/SARS-CoV are examples of beta coronaviruses. Human coronaviruses probably account for 5 to 10 percent of all acute upper respiratory tract infections in adults1.. Seasonally, coronaviruses are ubiquitous. In temperate climates, coronavirus respiratory infections occur primarily in the winter although sometimes these infections can peak in the fall or spring1.. ...
The Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe acute respiratory disease and systemic dysfunction that may eventually lead to the death of the patients. After MERS-CoV was first diagnosed in the South Korea, in May 2015, it affected 186 individuals and claimed 37 lives in short span of time (case fatality rate = 19.9%). Compared to MERS-CoV in the Middle East, MERS-CoV in South Korea appeared to be more transmissible, and induced multiple human-to-human transmission. These knowledge gaps caused the failure of early prevention, and disseminated MERS-CoV brought out a great loss of lives and economy. The MERS-CoV outbreak revealed the potential weakness of public health system in South Korea, and promoted the reestablishment of preventive strategies for imported infectious diseases. In these regards, we analyzed the potential for additional import of re-emerged and emerging infectious diseases, such as dengue fever, malaria, chikungunya fever and hepatitis A, from Africa ...
Clinicians, laboratories and public health practitioners should be aware that many Muslims from Australia will travel to Saudi Arabia in October to undertake the Hajj between 13 and 18 October, and may travel at other times to undertake the Umrah. Health professionals should be aware of the possibility of cases in travellers returning from the Hajj which ends on 18 October 2013.. The Saudi Ministry of Health recommends that elderly people and those with chronic diseases such as heart disease, kidney disease, respiratory disease and diabetes, as well as patients with congenital and acquired immune deficiency diseases, cancer patients, pregnant women and children, defer travel to Saudi Arabia for the Umrah and Hajj this year.. WHO advises that that pre-existing major medical conditions (e.g. chronic diseases such as diabetes or chronic bronchitis, immunodeficiency) can increase the likelihood of medical problems, including MERS-CoV infection, during travel; thus, pilgrims should consult their ...
TY - JOUR. T1 - Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus. AU - Josset, Laurence. AU - Menachery, Vineet D.. AU - Gralinski, Lisa E.. AU - Agnihothram, Sudhakar. AU - Sova, Pavel. AU - Carter, Victoria S.. AU - Yount, Boyd L.. AU - Graham, Rachel L.. AU - Baric, Ralph S.. AU - Katzea, Michael G.. PY - 2013. Y1 - 2013. N2 - A novel human coronavirus (HCoV-EMC) was recently identified in the Middle East as the causative agent of a severe acute respiratory syndrome (SARS) resembling the illness caused by SARS coronavirus (SARS-CoV). Although derived from the CoV family, the two viruses are genetically distinct and do not use the same receptor. Here, we investigated whether HCoV-EMC and SARS-CoV induce similar or distinct host responses after infection of a human lung epithelial cell line. HCoV-EMC was able to replicate as efficiently as SARS-CoV in Calu-3 cells and similarly induced minimal ...
On 18 April 2014, the Ministry of Health in Greece reported one laboratory-confirmed case of infection with Middle East respiratory syndrome coronavirus (MERS-CoV). This is the first case of MERS-CoV infection in Greece.
Rapid-response platforms are needed to control newly emerging virus pathogens. MERS-CoV likely emerged in the Middle East from exotic animals, perhaps bats, although the exact timing and origins of this pathogen in human populations remains unclear and is under study. MERS-CoV has caused 54 deaths at the time of writing (∼50% mortality), including documented instances of human-to-human transmission (3, 8). Therefore, the epidemic potential of MERS-CoV is high and its biology, life cycle, gene function, and pathogenic mechanisms clearly warrant additional study.. Developing full-length infectious cDNAs of emerging RNA viruses is assisted by the availability of high-throughput sequencing, gene synthesis, and the use of class II/IIS restriction endonucleases that allow seamless assembly of consensus synthetic cDNA fragments into full-length infectious cDNAs. In this instance, we synthesized a molecular clone from the published sequence, assembled full-length genomes, and isolated recombinant ...
An acute respiratory disease, caused by a novel coronavirus (SARS-CoV-2, previously known as 2019-nCoV), the coronavirus disease 2019 (COVID-19) has spread throughout China and received worldwide attention. On 30 January 2020, World Health Organization (WHO) officially declared the COVID-19 epidemic as a public health emergency of international concern. The emergence of SARS-CoV-2, since the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002 and Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012, marked the third introduction of a highly pathogenic and large-scale epidemic coronavirus into the human population in the twenty-first century. As of 1 March 2020, a total of 87,137 confirmed cases globally, 79,968 confirmed in China and 7169 outside of China, with 2977 deaths (3.4%) had been reported by WHO. Meanwhile, several independent research groups have identified that SARS-CoV-2 belongs to β-coronavirus, with highly identical genome to bat coronavirus, pointing to bat as the
WHO has issued Middle East respiratory syndrome coronavirus (MERS-CoV) - update. Excerpt: On 24 April 2014, the National IHR Focal Point (NFP) of Jordan reported a laboratory-confirmed case of Middle East Respiratory Syndrome coronavirus (MERS-CoV) infection in a 28 year-old...
WHO has convened an Emergency Committee under the International Health Regulations (IHR) to advise the Director-General on the status of the current situation. The Emergency Committee, which comprises international experts from all WHO Regions, unanimously advised that, with the information now available, and using a risk-assessment approach, the conditions for a Public Health Emergency of International Concern (PHEIC) have not at present been met. ...
TravelHealthPro is the website comprising the travel health resources of the National Travel Health Network and Centre (NaTHNaC).
We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.. ...
Corona in Gujarat , Corona update in Gujarat , corona virus test , coronavirus , coronavirus cases , coronavirus cases in india , coronavirus epidemic , coronavirus in india , coronavirus in india state wise , coronavirus india , coronavirus india news , coronavirus latest news , CoronaVirus News , coronavirus symptoms , coronavirus tips , coronavirus update , coronavirus update in india , coronavirus update india , covid 19 , india coronavirus cases , latest on coronavirus in india , light diyas , Lockdown , lockdown in Gujarat , Singapore , Singapore lockdown,coronavirus , coronavirus cases , coronavirus cases in india , coronavirus in india , coronavirus in india state wise , coronavirus india , coronavirus india news , coronavirus latest news , CoronaVirus News , coronavirus symptoms , coronavirus tips , coronavirus update , coronavirus update in india , coronavirus update india , gujarat coronavirus , Gujarat coronavirus death , Gujarat coronavirus death toll , india coronavirus cases , ...
Middle East respiratory syndrome coronavirus (MERS-CoV) is a lineage C betacoronavirus that since its emergence in 2012 has caused outbreaks in human populations with case-fatality rates of ∼36%. As in other coronaviruses, the spike (S) glycoprotein of MERS-CoV mediates receptor recognition and membrane fusion and is the primary target of the humoral immune response during infection. Here we use structure-based design to develop a generalizable strategy for retaining coronavirus S proteins in the antigenically optimal prefusion conformation and demonstrate that our engineered immunogen is able to elicit high neutralizing antibody titers against MERS-CoV. We also determined high-resolution structures of the trimeric MERS-CoV S ectodomain in complex with G4, a stem-directed neutralizing antibody. The structures reveal that G4 recognizes a glycosylated loop that is variable among coronaviruses and they define four conformational states of the trimer wherein each receptor-binding domain is either ...
Middle East Respiratory Syndrome (MERS) is a viral respiratory illness. First reported in Saudi Arabia in 2012, it has since spread to the U.S.
Background Korea failed in its risk communication during the early stage of the Middle East Respiratory Syndrome (MERS) outbreak; consequently, it faced difficulties in managing MERS, while disease-related worry increased. Disease-related worry can help disease prevention and management, but can also have a detrimental effect. This study measured the overall level of disease-related worry during the MERS outbreak period in Korea and the influencing factors and levels of disease-related worry during key outbreak periods. Methods The cross-sectional survey included 1,000 adults who resided in Korea. An ordinal logistic regression was performed for the overall level of MERS-related worry, and influencing factors of worry were analyzed. A reliability test was performed on the levels of MERS-related worry during key outbreak periods. Results The overall level of MERS-related worry was 2.44. Multivariate analysis revealed that women and respondents w very poor subjective health status had higher levels of
1. Matsuyama R, Nishiura H, Kutsuna S, Hayakawa K, Ohmagari N. Clinical determinants of the severity of Middle East respiratory syndrome (MERS): a systematic review and meta-analysis. BMC Public Health. 2016 Nov 29;16(1):1203.. 2. Dinh L, Chowell G, Mizumoto K, Nishiura H. Estimating the subcritical transmissibility of the Zika outbreak in the State of Florida, USA, 2016. Theor Biol Med Model. 2016 Nov 9;13(1):20.. 3. Nah K, Otsuki S, Chowell G, Nishiura H. Predicting the international spread of Middle East respiratory syndrome (MERS). BMC Infect Dis. 2016 Jul 22;16:356. doi: 10.1186/s12879-016-1675-z.. 4. Otsuki S, Nishiura H. Reduced Risk of Importing Ebola Virus Disease because of Travel Restrictions in 2014: A Retrospective Epidemiological Modeling Study. PLoS One. 2016 Sep 22;11(9):e0163418. doi: 10.1371/journal.pone.0163418.. 5. Nishiura H, Mizumoto K, Rock KS, Yasuda Y, Kinoshita R, Miyamatsu Y. A theoretical estimate of the risk of microcephaly during pregnancy with Zika virus infection. ...
A collaborative team from The University of Texas Medical Branch at Galveston, Saudi Arabia and Canada developed a potent and safe vaccine that protects against the deadly Middle East respiratory syndrome, or MERS.
Comments, concepts and statistics about Healthcare worker infected with Middle East respiratory syndrome during cardiopulmonary resuscitation in Korea, 2015.
The recently identified Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe and fatal acute respiratory illness in humans. However, no prophylactic and therapeutic agents specifically against MERS-CoV are currently available. Entry of MERS-CoV into target cells depends on binding of the receptor binding domain (RBD) of the viral envelope spike glycoprotein to the cellular receptor dipeptidyl peptidase 4 (DPP4). We report the isolation and characterization of two potent human RBD-specific neutralizing monoclonal antibodies (MERS-4 and MERS-27) derived from single-chain variable region fragments of a nonimmune human antibody library. MERS-4 and MERS-27 inhibited infection of both pseudotyped and live MERS-CoV with IC50 (half-maximal inhibitory concentration) at nanomolar concentrations. MERS-4 also showed inhibitory activity against syncytia formation mediated by interaction between MERS-CoV spike glycoprotein and DPP4. Combination of MERS-4 and MERS-27 demonstrated a synergistic ...
Professor Paul Kellam of Imperial College London is an expert on the genetics of viruses. His team delivered the genome analysis that helped to tackle a previous coronavirus outbreak, the Middle East Respiratory Syndrome Coronavirus, known as Mers.. Each time a coronavirus moves from one person to the next, there is a slight genetic mutation, says Prof Kellam, allowing researchers to map its "family tree".. So when a version of the virus is analysed from any new location, it is possible to see how it compares with samples from the original outbreak in Wuhan, or its relationship to other offshoots of the virus in other countries.. Researchers in Milan reported that the version of the coronavirus in Lombardy matched an outbreak in Germany, centred on a businessman from Munich who had met a woman from Shanghai carrying the virus.. This would mean that while the Italian authorities were closing the air routes from China, the virus could have already arrived from Germany.. There were questions about ...
MERS is caused by a virus called Middle East Respiratory Syndrome Coronavirus (MERS-CoV), which belongs to the Coronavirus family of viruses. MERS Virus belongs to the genus Betacoronavirus. Coronavirus family of viruses includes viruses that usually cause respiratory tract illnesses like the common cold in human beings, and also, these viruses cause a number of diseases in animals. Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) causes Severe Acute Respiratory Syndrome (SARS).. Continue reading → ...
The global novel coronavirus (COVID‐19 or 2019‐CoV) issue has posed significant threats to international human health and the economy, human are fighting this novel coronavirus together. Omega-3 polyunsaturated fatty acids and antiviral treatments should be useful in fighting novel coronavirus (COVID‐19).
Dromedaries in Africa and elsewhere carry the Middle East respiratory syndrome coronavirus (MERS-CoV). To search for evidence of autochthonous MERS-CoV infection in humans, we tested archived serum from livestock handlers in Kenya for MERS-CoV antibodies. Serologic evidence of infection was confirmed for 2 persons sampled in 2013 and 2014 ...
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period from 4-10 November 2018 and includes updates on Middle East respiratory syndrome Middle East respiratory syndrome coronavirus (MERS-CoV), measles, influenza, influenza A(H5N6), West Nile virus, Ebola virus disease, dengue and malaria. ...
Summary_MERS-CoV_15Apr15_final.pdf (573.1 KB) Recent evolution patterns of the Middle East respiratory syndrome coronavirus (MERS-CoV) Mazin A. Barry MD1, Sarah S. Al Subaie MD[2], Ali M. Somily MD[3], Abdulaziz A. Bin…
Coronavirus , Human Coronavirus Types , CDC. Human Coronavirus Types - Common human coronaviruses In other projects Wikispecies Wikiquote.. Alphacoronavirus Betacoronavirus Gammacoronavirus Deltacoronavirus. A number of the nonstructural proteins coalesce to form a multi-protein replicase-transcriptase complex RTC. Retrieved Bibcode : Sci Global research Technical guidelines. Taxon identifiers. Palinsesto Podcast Programmi Conduttori.https://www.cdc.gov/coronavirus/index.html Il coronavirus novello SARS-CoV-2, anche conosciuto come nCoV, è il virus che causa COVID e che sta spargendosi nel mondo intero sta causando il panico in quasi tutti i paesi. Con un. Coronaviruses are a group of related viruses that cause diseases in mammals and www.qarantino.com humans, coronaviruses cause respiratory tract infections that can be mild, such as some cases of the common cold (among other possible causes, predominantly rhinoviruses), and others that can be lethal, such as SARS, MERS, and COVIDSymptoms in ...
As more companies send employees on global travel, its important for safety and health managers to have a proper infection control system. If an employee contracts an infectious disease, the possibility of spreading it throughout the company could develop into a serious problem for the employer.. For instance, between November 2002 and July 2003, an outbreak of a terrible viral respiratory illness caused by a coronavirus occurred in South China. This disease, Severe Acute Respiratory Syndrome coronavirus (SARS-CoV), was on the verge of becoming a pandemic. According to the World Health Organization (WHO), there were 8,098 cases and 774 deaths worldwide. In general, SARS begins with a high fever and can lead to other symptoms such as headaches, an overall feeling of discomfort and body aches. The illness spread to more than two dozen countries before the 2003 outbreak was contained.. In April 2012, a new coronavirus emerged in the Middle East: Middle East Respiratory Syndrome Coronavirus ...
We establish new minimum protein requirements for the formation of double-membrane vesicles (DMVs), a prototypic type of virus-induced membrane structure that also plays a role in the replication of other viral pathogens. We demonstrate a direct link between membrane remodelling and viral polyprotein processing and reveal the likely DMV biogenesis mechanism.. This work was done in close collaboration between the departments of Molecular Virology and Cell and Chemical Biology at the LUMC.. Oudshoorn, D., Rijs, K., Limpens, R., Groen, K., Koster, A.J., Snijder, E.J., Kikkert, M. and Barcena, M., "Expression and Cleavage of Middle East Respiratory Syndrome Coronavirus Nsp3-4 Polyprotein Induce the Formation of Double-Membrane Vesicles That Mimic Those Associated with Coronaviral Rna Replication" (2017) MBio, 8, 6.. ...
WHO immediately alerted all its Member States about the novel coronavirus and has been leading the coordination of and providing guidance to health authorities and technical health agencies. A joint Republic of Korea-WHO high-level mission was undertaken in June 2015 with the aim of gaining information and reviewing the situation. The team has also assessed the public health response efforts and provided its recommendations.. The IHR Emergency Committee convened by the WHO Director-General held its ninth meeting regarding MERS-CoV on 16 June 2015. The Committee concluded that the conditions for a public health emergency of international concern have not been met. WHO/Europe will continue to provide input to all aspects of this response, including participating in risk assessment, providing support to Member States that have had cases, supporting surveillance and laboratory capacities and disseminating information.. WHO/Europe in collaboration with the European Centre for Disease Prevention and ...
Middle East Respiratory Syndrome (MERS) is a viral respiratory illness. First reported in Saudi Arabia in 2012, it has since spread to the U.S.
Since the Middle East respiratory syndrome coronavirus (MERS-CoV) first emerged in Saudi Arabia in 2012, there have been more than 2,400 confirmed cases of the infection, resulting in greater than 800 deaths - an alarming fatality rate of 35 percent. For this reason, researchers have been eager to identify any risk factors that contribute to the development of severe or lethal disease. Current clinical evidence points to diabetes as a major risk factor in addition to other comorbidities including kidney disease, heart disease, and lung disease.. Researchers from the University of Maryland School of Medicine (UMSOM) and the Johns Hopkins University School of Medicine have demonstrated in a new study, published earlier this week in the Journal of Clinical Investigation Insights, how diabetes contributes to mortality from MERS-CoV infections, and the finding could shed light on why other respiratory illnesses like the flu or pneumonia might strike those with diabetes more severely.. They ...
During the course of this project, we witnessed the emergence of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). MERS-CoV is associated with severe respiratory disease and has an exceptionally high case fatality of approximately 40%. Initially, it was not known either how efficiently the MERS-CoV could replicate on the human airway epithelium or whether any measures were available to inhibit MERS-CoV replication in the human airway epithelium, indeed, even the nature of the target cell(s) was unknown. Since primary HAE-cultures were immediately at our command, we could participate in a number of international studies. We were the first to demonstrate that MERS-CoV can efficiently replicate on the primary human epithelium, which highlights its zoonotic potential (2).. Importantly, the treatment of MERS-CoV-infected HAE-cultures with interferon-alpha and interferon-lambda significantly reduced viral replication. Hence, this strategy opens up a therapeutic option for MERS-CoV patients ...
Via InterAksyon.com, a PNA report: PH remains MERS-CoV free, but health check continues - DOH. Excerpt: Over a month after a returning overseas Filipino worker (OFW) initially tested positive for Middle East Respiratory Syndrome coronavirus (MERS-CoV), the Department of Health...
Simply stated, coronaviruses (CoV) constitute a huge community of viruses. Various strains of the virus may cause multiple ill-health conditions ranging from cold or flu to more extreme conditions, such as Middle East Respiratory Syndrome (MERS-CoV, or simply MERS) and Severe Acute Respiratory Syndrome (SARS-CoV, or simply SARS). Coronaviruses are highly zoonotic, meaning they are transferable between animals and humans. An example is the SARS, which was introduced to humans from civet cats, while the MERS initially originated from camels. There exist different coronavirus strains that are spreading between animals, but until now, they have not affected humans.. Whenever you read through the news and encounter instances of coronavirus, they simply apply to either the new strain of coronavirus or COVID-19, another new strain of coronavirus that hasnt been reported in humans before and has circulated since late 2019. I will clearly address the COVID-19 in this article and will often refer to this ...
LAGOS State Government, alerted its indigenes traveling to other parts of the world with confirmed cases of coronavirus infections - a severe, life-threatening respiratory disease - to take adequate precautions to protect themselves from the infection. The coronavirus known as Middle East Respiratory Syndrome Coronavirus (MERS-CoV, is currently ravaging countries in the Middle East and…
In a surprise finding, South Korean researchers observed point mutations in MERS-CoV isolates that rendered the virus less virulent as the outbreak in that country spread last year, a finding that may have ramifications for vaccine development, according to a study today in mBio.. The scientists isolated 13 viral genomes from 14 patients infected with MERS-CoV (Middle East respiratory syndrome coronavirus) in late spring through July last year in South Korea. They found that 12 of the genomes had two specific mutations (I529T and D510G) in the receptor-binding domain (RBD) of the viruss spike protein.. They also determined that the mutations impaired viral fitness and virulence, rather than making the virus more virulent, or capable of causing severe disease.. "This is an interesting strategy of coronavirus evolution to survive in nature and live together with the new host. The virus may tune down its power to attack for the sake of longer survival in the new host," said principal investigator ...
If you would say YES to any of the above, do NOT report to NDBC. If you have traveled out of country in the past 30 days and/or been in contact with an individual with a positive laboratory COVID-19 test, you cannot be seen in person for 14 days. However, you may still be appropriate for our Telehealth program, please call Teresa at 952-800-8951.. _________________________________________________________________________. What is COVID-19..?. On February 11, 2020 the World Health Organization announced an official name for the disease that is causing the 2019 novel coronavirus outbreak, first identified in Wuhan China. The new name of this disease is coronavirus disease 2019, abbreviated as COVID-19. In COVID-19, CO stands for corona, VI for virus, and D for disease. Formerly, this disease was referred to as "2019 novel coronavirus" or "2019-nCoV".. A novel coronavirus is a new coronavirus that has not been previously identified. The virus causing coronavirus disease 2019 (COVID-19), is ...
WHO/Europe aim to reduce influenza-related morbidity and mortality by strengthening virological and epidemiological surveillance for mild and severe influenza; using surveillance data to estimate the burden of influenza in order to prioritize national influenza vaccination programmes; and maintaining and strengthening pandemic preparedness activities at the national level. WHO/Europe also monitors the emergence of other respiratory pathogens that have the potential to spread among humans. These include coronaviruses, which cause a range of illnesses from severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome coronavirus (MERS-CoV) to the common cold.. ...
Every virus needs a catchy name, and now the new coronavirus linked to the Middle East that has infected 40 people and killed half of them has one: Middle East Respiratory Syndrome Coronavirus or (MERS-CoV). Various scientists have been calling it MERS,
Tse, L.V., Marcano, V.C., Huang. W., Pocwierz, M.S. and Whittaker, G.R. (2013). Plasmin-mediated activation of pandemic H1N1 influenza virus hemagglutinin independent of the viral neuraminidase. J. Virol. 87: 5161-5169 Licitra, B.N., Sams, K.L. Lee, D.W. and Whittaker G.R. (2014). Feline coronaviruses associated with feline infectious peritonitis have modifications to spike protein activation sites at two discrete positions. ArXiV.http://arxiv.org/abs/1412.4034. Costello, D.A., Whittaker, G.R. and Daniel, S. (2015).Variation of pH sensitivity, acid stability, and fusogenicity of three influenza H3 subtypes. J. Virol. 89(1):350-360.http://www.ncbi.nlm.nih.gov/pubmed/25320308. Millet, J.K. and Whittaker, G.R. Host cell entry of Middle East respiratory syndrome coronavirus following two-step, furin-mediated activation of spike protein. Proc Natl Acad Sci.:http://www.pnas.org/content/early/2014/10/02/1407087111.abstract Hamilton, B.S., Chung, C., Cyphers, S., Rinaldi, V.D., Marcano, V., and ...
As of this writing, there is NO specific medicine to treat or prevent 2019-nCoV. But for those who have been infected, appropriate care should be given to relieve and treat symptoms. Furthermore, those with severe illnesses should receive the best possible supportive care.. As the virus continues to spread, it is vital for everyone to be updated about the latest news, including preventive measures and possible treatments. More importantly, we should remain calm and rely only on trusted information sources. Speaking of which, here are some tips for protecting yourself against the novel coronavirus, issued by the Department of Health (DOH).. DISCLAIMER: The details above are presented for information-sharing purposes only. To know more about the latest news and advisories on the novel coronavirus or 2019-nCoV, please visit the official website of the World Health Organization (WHO).. ...
Russia has confirmed its first two cases of the novel coronavirus on Friday in the Trans-Baikal and Tyumen regions.. The patients are Chinese nationals who have been hospitalized and are in stable condition, said Anna Popova, head of Russias consumer rights and human wellbeing watchdog Rospotrebnadzor.. Russia will take measures to prevent the spread of the novel coronavirus in the country, said Russian Deputy Prime Minister Tatyana Golikova, adding the country is ready to offer assistance to China.. ...
Following the sudden and unexpected emergence of influenza A(H1N1)pdm09 (2009 H1N1) virus, this observational study was initiated to estimate rates of morbidity and mortality and to examine predictors of severity among participants with 2009 H1N1 infection. In 2011, as surveillance indicated that 2009 H1N1 virus was co-circulating with other seasonal influenza A and B viruses worldwide, the protocol was expanded to include other influenza A subtypes and influenza B viruses. The current version of the protocol (released in August 2013) further broadens the scope of this observational study. With the recognition that novel respiratory viruses other than novel influenza A viruses, e.g., Middle East Respiratory Syndrome Coronavirus (MERS-CoV), could become prevalent and of major public health importance, the objectives of this protocol have been expanded ...